COMBATING INFECTION THROUGH ATOMIC-SCALE MODELING OF UNIQUE BACTERIAL SYSTEMS
通过独特细菌系统的原子尺度建模来对抗感染
基本信息
- 批准号:8653533
- 负责人:
- 金额:$ 10.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-05-01 至 2016-04-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAnti-Bacterial AgentsAntibioticsBacteriaBacterial Drug ResistanceBacterial InfectionsBindingCause of DeathCell WallCollaborationsCommunicable DiseasesComputer softwareComputing MethodologiesDataDevelopmentDiffusionDrug DesignDrug ReceptorsDrug TargetingDrug resistanceEnzyme InteractionEnzymesGoalsGram-Negative BacteriaHealthHumanInfectionInterventionLeadLengthLipidsMediatingMembraneModelingMolecularMolecular ConformationMolecular ModelsMotorNatureOrganismPathway interactionsPharmaceutical PreparationsPlayProcessProtein translocationProteinsResistanceResourcesRestRoleShapesStructureSupercomputingSystemTherapeutic InterventionTimeadvanced simulationcombatcomputerized toolsdesigndrug discoverydrug efficacyglycosylationinhibitor/antagonistinsightmolecular dynamicsmolecular modelingnext generationnovelnovel strategiespathogenic bacteriaresistance mechanismsimulationtranslocasevirtual
项目摘要
DESCRIPTION (provided by applicant): Infectious diseases are the second leading cause of death in the world. With novel classes of antibiotic drugs virtually nonexistent, and the resistance of pathogenic bacteria to current ones increasing rapidly, the development of new approaches is becoming an imperative for advancing human health efforts. Molecular modeling will play an essential role in these new approaches, due to the fundamentally atomic-scale nature of the critical structures, processes, and interactions underlying the action of both antibacterial agents and resistance mechanisms. In order to illuminate these structures and processes, the PI will focus on three systems specific and essential to bacteria: the bacterial cel wall, the outer membrane, and the SecA protein translocase. The cell wall provides shape and strength to bacteria, and is a canonical antibacterial target, yet its mesoscale structure remains unknown. In the first aim, the interaction of the enzymes synthesizing the cell wall with its underlying components will be modeled, permitting novel antibacterial agents that can also overcome drug resistance to be developed. In Gram-negative bacteria, the outer membrane rests beyond the cell wall and presents one of the greatest barriers to the entry of drug molecules. Furthermore, by modulating the few available entry pathways through existing protein channels, it plays a crucial role in drug efficacy. In the second aim, the PI will quantify
this modulation and its effect on drug influx. Finally, in the third aim, the PI will determine the
functional cycle of SecA, an ATP driven motor that enables the translocation of nascent proteins across membranes. By using structural data generated in the process, SecA will be exploited as a novel antibacterial target. All aims rely on advanced computational tools and methods, including cutting-edge molecular dynamics simulations. These simulations, which furnish dynamic views spanning a wide range of length and time scales, are enabled, in particular, by the emergence of petascale supercomputing resources and the software necessary to take full advantage of them.
描述(申请人提供):传染病是全球第二大致死原因。随着新型抗生素药物的几乎不存在,以及病原菌对现有药物的耐药性迅速增加,开发新的方法正成为推进人类健康努力的当务之急。分子模拟将在这些新方法中发挥重要作用,因为抗菌剂和耐药机制的关键结构、过程和相互作用的本质是原子尺度的。为了阐明这些结构和过程,PI将集中在细菌特有的和必不可少的三个系统上:细菌细胞壁、外膜和SecA蛋白转位酶。细胞壁为细菌提供形状和强度,是典型的抗菌目标,但其中尺度结构尚不清楚。在第一个目标中,将模拟合成细胞壁的酶与其底层成分的相互作用,从而开发出也可以克服耐药性的新型抗菌剂。在革兰氏阴性细菌中,外膜位于细胞壁之外,是药物分子进入的最大障碍之一。此外,通过现有的蛋白质通道调节少数可用的进入途径,它在药物疗效中起着至关重要的作用。在第二个目标中,PI将量化
这种调节及其对药物流入的影响。最后,在第三个目标中,PI将决定
SECA的功能循环,这是一种由三磷酸腺苷驱动的马达,使新生蛋白质能够跨膜转运。通过使用在此过程中产生的结构数据,SecA将被开发为新的抗菌靶点。所有的目标都依赖于先进的计算工具和方法,包括尖端的分子动力学模拟。这些模拟提供了跨越广泛长度和时间范围的动态视图,尤其是由于千万亿级超级计算资源的出现和充分利用这些资源所必需的软件的出现。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Thermodynamics of Deca-alanine Folding in Water.
- DOI:10.1021/ct5002076
- 发表时间:2014-07-08
- 期刊:
- 影响因子:5.5
- 作者:Hazel, Anthony;Chipot, Christophe;Gumbart, James C.
- 通讯作者:Gumbart, James C.
The adaptive biasing force method: everything you always wanted to know but were afraid to ask.
- DOI:10.1021/jp506633n
- 发表时间:2015-01-22
- 期刊:
- 影响因子:0
- 作者:Comer J;Gumbart JC;Hénin J;Lelièvre T;Pohorille A;Chipot C
- 通讯作者:Chipot C
Parametrization of macrolide antibiotics using the force field toolkit.
- DOI:10.1002/jcc.24043
- 发表时间:2015-10-15
- 期刊:
- 影响因子:3
- 作者:Pavlova A;Gumbart JC
- 通讯作者:Gumbart JC
The mechanism of the amidases: mutating the glutamate adjacent to the catalytic triad inactivates the enzyme due to substrate mispositioning.
酰胺酶的机制:使催化三联体附近的谷氨酸发生突变,由于底物错位而使酶失活。
- DOI:10.1074/jbc.m113.503284
- 发表时间:2013
- 期刊:
- 影响因子:0
- 作者:Weber,BrandonW;Kimani,SerahW;Varsani,Arvind;Cowan,DonaldA;Hunter,Roger;Venter,GerhardA;Gumbart,JamesC;Sewell,BTrevor
- 通讯作者:Sewell,BTrevor
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
James C. Gumbart其他文献
From closed to open: Addressing the role of the efflux pump AcrAB-TolC in antibiotic resistance
- DOI:
10.1016/j.bpj.2022.11.1689 - 发表时间:
2023-02-10 - 期刊:
- 影响因子:
- 作者:
Katie M. Kuo;Helen I. Zgurskaya;James C. Gumbart - 通讯作者:
James C. Gumbart
Resolving large conformational change pathways through machine learning and enhanced sampling simulations
- DOI:
10.1016/j.bpj.2021.11.551 - 发表时间:
2022-02-11 - 期刊:
- 影响因子:
- 作者:
Yui Tik Pang;James C. Gumbart - 通讯作者:
James C. Gumbart
From static to dynamic: Rapid mapping of protein conformational transitions using DeepPath
- DOI:
10.1016/j.bpj.2023.11.349 - 发表时间:
2024-02-08 - 期刊:
- 影响因子:
- 作者:
Yui Tik Pang;Lixinhao Yang;James C. Gumbart - 通讯作者:
James C. Gumbart
Antibody-LPS interactions in invasive non-typhoidal <em>Salmonella</em> infections: Coarse-grained simulations of outer membrane dynamics
- DOI:
10.1016/j.bpj.2023.11.2934 - 发表时间:
2024-02-08 - 期刊:
- 影响因子:
- 作者:
Gvantsa Gutishvili;Vassiliy N. Bavro;Adam F. Cunningham;James C. Gumbart - 通讯作者:
James C. Gumbart
Molecular insight into the transport of TMMs by MmpL3 in Mtb
- DOI:
10.1016/j.bpj.2021.11.444 - 发表时间:
2022-02-11 - 期刊:
- 影响因子:
- 作者:
Lixinhao Yang;Yupeng Li;Atanu Acharya;Jinchan Liu;Helen I. Zgurskaya;Mary Jackson;James C. Gumbart - 通讯作者:
James C. Gumbart
James C. Gumbart的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('James C. Gumbart', 18)}}的其他基金
Elucidating the mechanisms of protein secretion across the outer membrane by bacterial autotransporters
阐明细菌自转运蛋白跨外膜分泌蛋白质的机制
- 批准号:
10736193 - 财政年份:2023
- 资助金额:
$ 10.75万 - 项目类别:
Integrative and Quantitative Biosciences Accelerated Training Environment
综合和定量生物科学加速培训环境
- 批准号:
10620308 - 财政年份:2021
- 资助金额:
$ 10.75万 - 项目类别:
Altering Hepatitis B Virus assembly through pharmacological intervention
通过药物干预改变乙型肝炎病毒组装
- 批准号:
10159864 - 财政年份:2020
- 资助金额:
$ 10.75万 - 项目类别:
Altering Hepatitis B Virus assembly through pharmacological intervention
通过药物干预改变乙型肝炎病毒组装
- 批准号:
10394388 - 财政年份:2020
- 资助金额:
$ 10.75万 - 项目类别:
Altering Hepatitis B Virus assembly through pharmacological intervention
通过药物干预改变乙型肝炎病毒组装
- 批准号:
10618786 - 财政年份:2020
- 资助金额:
$ 10.75万 - 项目类别:
Dynamic characterization of outer-membrane-protein biogenesis by the BAM and TAM complexes
BAM 和 TAM 复合物外膜蛋白生物合成的动态表征
- 批准号:
10204038 - 财政年份:2017
- 资助金额:
$ 10.75万 - 项目类别:
Dynamic characterization of outer-membrane-protein biogenesis by the BAM and TAM complexes
BAM 和 TAM 复合物外膜蛋白生物合成的动态表征
- 批准号:
9398209 - 财政年份:2017
- 资助金额:
$ 10.75万 - 项目类别:
COMBATING INFECTION THROUGH ATOMIC-SCALE MODELING OF UNIQUE BACTERIAL SYSTEMS
通过独特细菌系统的原子尺度建模来对抗感染
- 批准号:
8351847 - 财政年份:2013
- 资助金额:
$ 10.75万 - 项目类别:
相似国自然基金
烯基环烷醇的电促开环官能化反应研究及其在抗菌剂Alatanones A合
成中的应用
- 批准号:
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于金属-有机框架(MOFs)的多元手性纳米
光控抗菌剂对水产弧菌病病原菌的抗菌活性
及机理探究
- 批准号:Q24C190019
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
新污染物抗菌剂的水生态风险识别与阻控
- 批准号:n/a
- 批准年份:2023
- 资助金额:100.0 万元
- 项目类别:省市级项目
基于乏氧增强型超声抗菌剂的细菌生物膜感染协同治疗研究
- 批准号:22375101
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
基于声动力的高效靶向抗菌剂开发及其用于幽门螺杆菌感染治疗的研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
非典型I-型聚酮类抗菌剂NFAT-133的芳构化机理
- 批准号:32211530074
- 批准年份:2022
- 资助金额:10 万元
- 项目类别:
脑靶向新型反义抗菌剂递送系统的构建、评价及其递送机理研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于呫吨酮的拟肽抗菌剂设计合成、抗菌活性和分子机制研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
二(苯乙烯基)酮类光敏抗菌剂的设计,合成及应用研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
土壤真菌群落对典型三唑类抗菌剂的抗药性响应特征和机制
- 批准号:
- 批准年份:2022
- 资助金额:53 万元
- 项目类别:面上项目
相似海外基金
New technologies for targeted delivery of anti-bacterial agents
抗菌药物靶向递送新技术
- 批准号:
1654774 - 财政年份:2015
- 资助金额:
$ 10.75万 - 项目类别:
Studentship
Targeting bacterial phosphatases for novel anti-bacterial agents.
针对细菌磷酸酶的新型抗菌剂。
- 批准号:
8416313 - 财政年份:2012
- 资助金额:
$ 10.75万 - 项目类别:
Targeting bacterial phosphatases for novel anti-bacterial agents.
针对细菌磷酸酶的新型抗菌剂。
- 批准号:
8298885 - 财政年份:2012
- 资助金额:
$ 10.75万 - 项目类别: